Leaflet BICALUTAMIDA ALVOGEN 50mg film-coated tablets
Indicated for: prostate cancer
Route of administration: oral
Substance: bicalutamide (antiandrogen)
ATC: L02BB03 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens)
This medicine may affect fertility.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
This medicine may affect fetal development.
Bicalutamide is an antiandrogen medication primarily used for the treatment of advanced prostate cancer. It works by blocking androgen receptors, thereby reducing the effects of male hormones (testosterone) on prostate cancer cells. It is often used in combination with other therapies, such as gonadotropin-releasing hormone (GnRH) analogs.
Bicalutamide is taken orally, usually once daily, and is well-tolerated by most patients. Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea. In rare cases, it may affect liver function, so regular liver monitoring is recommended.
The medication is contraindicated in women, especially during pregnancy or breastfeeding, and is not recommended for use in children. It is important for patients to strictly follow their doctor’s instructions and not discontinue treatment without medical advice.
General data about BICALUTAMIDA ALVOGEN 50mg
- Substance: bicalutamide
- Date of last drug list: 01-01-2019
- Commercial code: W58039001
- Concentration: 50mg
- Pharmaceutical form: film-coated tablets
- Quantity: 28
- Product type: generic
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Concentrations available for bicalutamide
- 150mg
- 50mg